Essec\Faculty\Model\Contribution {#2233
  #_index: "academ_contributions"
  #_id: "549"
  #_source: array:26 [
    "id" => "549"
    "slug" => "a-markov-model-simulation-of-the-impact-of-treatment-persistence-in-postmenopausal-osteoporosis"
    "yearMonth" => "2009-01"
    "year" => "2009"
    "title" => "A Markov Model Simulation of the Impact of Treatment Persistence in Postmenopausal Osteoporosis"
    "description" => "COTTE, F.E., FAUTREL, B. et PUYOU DE POUVOURVILLE, G. (2009). A Markov Model Simulation of the Impact of Treatment Persistence in Postmenopausal Osteoporosis. <i>Medical Decision Making</i>, 29(1), pp. 125-139."
    "authors" => array:3 [
      0 => array:3 [
        "name" => "PUYOU DE POUVOURVILLE Gérard"
        "bid" => "B00072308"
        "slug" => "de-pouvourville-gerard"
      ]
      1 => array:1 [
        "name" => "COTTE F.-E."
      ]
      2 => array:1 [
        "name" => "FAUTREL B."
      ]
    ]
    "ouvrage" => ""
    "keywords" => []
    "updatedAt" => "2020-12-17 17:55:06"
    "publicationUrl" => null
    "publicationInfo" => array:3 [
      "pages" => "125-139"
      "volume" => "29"
      "number" => "1"
    ]
    "type" => array:2 [
      "fr" => "Articles"
      "en" => "Journal articles"
    ]
    "support_type" => array:2 [
      "fr" => "Revue scientifique"
      "en" => "Scientific journal"
    ]
    "countries" => array:2 [
      "fr" => null
      "en" => null
    ]
    "abstract" => array:2 [
      "fr" => "L'ostéoporose est une maladie fréquente du squelette qui fragilise les os  et augmente le risque de fracture. Les biphosphonates ont démontré leur efficacité dans la prévention fracturaire, mais cette efficacité est limitée par la mauvaise observance au traitement des patients. Unmodèle a été développé pour estimer le gain d'efficacité lié à la disponibilité dun traitement favorisant l'observance."
      "en" => "Osteoporosis is a common disorder of the skeleton that increases bone fragility and the risk of fracture. Bisphosphonates have become the reference treatment for postmenopausal osteoporosis because of their proven efficacy in reducing fracture rates. The effectiveness of bisphosphonates is, however, limited by poor treatment adherence and persistence with treatment. A model has been designed to simulate the impact of improving persistence rates on treatment effectiveness."
    ]
    "authors_fields" => array:2 [
      "fr" => "Management"
      "en" => "Management"
    ]
    "indexedAt" => "2024-11-22T06:21:50.000Z"
    "docTitle" => "A Markov Model Simulation of the Impact of Treatment Persistence in Postmenopausal Osteoporosis"
    "docSurtitle" => "Articles"
    "authorNames" => "<a href="/cv/de-pouvourville-gerard">PUYOU DE POUVOURVILLE Gérard</a>, COTTE F.-E., FAUTREL B."
    "docDescription" => "<span class="document-property-authors">PUYOU DE POUVOURVILLE Gérard, COTTE F.-E., FAUTREL B.</span><br><span class="document-property-authors_fields">Management</span> | <span class="document-property-year">2009</span>"
    "keywordList" => ""
    "docPreview" => "<b>A Markov Model Simulation of the Impact of Treatment Persistence in Postmenopausal Osteoporosis</b><br><span>2009-01 | Articles </span>"
    "docType" => "research"
    "publicationLink" => "<a href="#" target="_blank">A Markov Model Simulation of the Impact of Treatment Persistence in Postmenopausal Osteoporosis</a>"
  ]
  +lang: "fr"
  +"_type": "_doc"
  +"_score": 9.0641575
  +"parent": null
}